Clinical Trials Directory

Trials / Terminated

TerminatedNCT03763682

BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse

A Multicentre, Prospective, Open-label, 2 Groups Study to Assess the Safety and Performance of the Genio™ Bilateral Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnoea in Adult Patients With and Without Complete Concentric Collapse of the Soft Palate

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Nyxoah S.A. · Industry
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to explore the safety and performance of the Genio™ system in adult obstructive sleep apnoea (OSA) patients with and without complete concentric collapse of the soft palate over a period of 4.5 months of treatment (i.e. 6 months post-surgery) measured by the AHI, at rest to determine if there is a difference in performance between the two populations.

Detailed description

This is a prospective, open-label, multicentric, 2 groups study to assess the safety and performance of the Genio™ system in adult obstructive sleep apnoea (OSA) patients with and without complete concentric collapse of the soft palate. Participants will be consented, enrolled and eligibility criteria checked. If the participant is eligible, participant will proceed with the Genio™ IS implantation. Six (6) weeks after implantation, the implant will be activated and study visits will be scheduled at Week 7, Month 2, Month 3, Month 4, Month 5 and Month 6.

Conditions

Interventions

TypeNameDescription
DEVICEGenio(TM) bilateral hypoglossal nerve stimulation systemSubjects will be consented, enrolled and eligibility criteria checked. If the subject is eligible, subject will proceed with the Genio(TM) implant implantation. Six (6) weeks after implantation, the implant will be activated and the subject will be assessed at 1 month plus 1 week, 2, 3, 4, 5 and 6 month(s) after implantation

Timeline

Start date
2019-01-10
Primary completion
2021-06-28
Completion
2024-06-18
First posted
2018-12-04
Last updated
2025-06-06

Locations

4 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT03763682. Inclusion in this directory is not an endorsement.